Comparison of Dydrogesterone Alone Versus Dydrogesterone Plus HCG in Threatened Miscarriage
ClinicalTrials.gov · NCT07608133 · Registry updated: 2026-05-27
- Condition / research focus
- Threatened Miscarriage; Early Pregnancy Bleeding
- Sponsor
- Pakistan Air Force (PAF) Hospital Islamabad
- Countries with listed sites
- Pakistan
- Registry dates and results
- Start: 2025-12-09. Completion: 2026-05-15 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Dydrogesterone (drug)
- Human chorionic gonadotrophin (hCG) (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Pakistan Air Force Hospital, Islamabad
Islamabad, Punjab Province, Pakistan